194 related articles for article (PubMed ID: 26149860)
1. Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection.
Chuquiyauri R; Molina DM; Moss EL; Wang R; Gardner MJ; Brouwer KC; Torres S; Gilman RH; Llanos-Cuentas A; Neafsey DE; Felgner P; Liang X; Vinetz JM
Am J Trop Med Hyg; 2015 Oct; 93(4):801-9. PubMed ID: 26149860
[TBL] [Abstract][Full Text] [Related]
2. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
3. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis for structure, function and T-cell epitopes of a hypothetical conserved (HP-C) protein coded by PVX_092425 in Plasmodium vivax.
Mo J; Li J
Pathog Glob Health; 2015 Mar; 109(2):61-7. PubMed ID: 25706099
[TBL] [Abstract][Full Text] [Related]
6. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.
França CT; Hostetler JB; Sharma S; White MT; Lin E; Kiniboro B; Waltmann A; Darcy AW; Li Wai Suen CS; Siba P; King CL; Rayner JC; Fairhurst RM; Mueller I
PLoS Negl Trop Dis; 2016 May; 10(5):e0004639. PubMed ID: 27182597
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
8. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
10. Genetic diversity and allelic variation in MSP3α gene of paired clinical Plasmodium vivax isolates from Delhi, India.
Kaul A; Bali P; Anwar S; Sharma AK; Gupta BK; Singh OP; Adak T; Sohail M
J Infect Public Health; 2019; 12(4):576-584. PubMed ID: 30824330
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).
Cassiano GC; Furini AA; Capobianco MP; Storti-Melo LM; Almeida ME; Barbosa DR; Póvoa MM; Nogueira PA; Machado RL
Malar J; 2016 Jun; 15():306. PubMed ID: 27255376
[TBL] [Abstract][Full Text] [Related]
13. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA).
Lu F; Li J; Wang B; Cheng Y; Kong DH; Cui L; Ha KS; Sattabongkot J; Tsuboi T; Han ET
J Proteomics; 2014 May; 102():66-82. PubMed ID: 24607491
[TBL] [Abstract][Full Text] [Related]
14. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
15. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti.
Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA
Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796
[TBL] [Abstract][Full Text] [Related]
16. Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.
Stanisic DI; Javati S; Kiniboro B; Lin E; Jiang J; Singh B; Meyer EV; Siba P; Koepfli C; Felger I; Galinski MR; Mueller I
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2498. PubMed ID: 24244763
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays.
Uplekar S; Rao PN; Ramanathapuram L; Awasthi V; Verma K; Sutton P; Ali SZ; Patel A; G SL; Ravishankaran S; Desai N; Tandel N; Choubey S; Barla P; Kanagaraj D; Eapen A; Pradhan K; Singh R; Jain A; Felgner PL; Davies DH; Carlton JM; Das J
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005323. PubMed ID: 28118367
[TBL] [Abstract][Full Text] [Related]
18. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
19. Merozoite surface protein-3 alpha as a genetic marker for epidemiologic studies in Plasmodium vivax: a cautionary note.
Rice BL; Acosta MM; Pacheco MA; Escalante AA
Malar J; 2013 Aug; 12():288. PubMed ID: 23964962
[TBL] [Abstract][Full Text] [Related]
20. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
